| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,357 |
5,612 |
$205K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,028 |
2,226 |
$92K |
| 99348 |
|
704 |
596 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,518 |
2,108 |
$33K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
850 |
659 |
$29K |
| 99384 |
|
321 |
302 |
$27K |
| 99335 |
|
436 |
326 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,746 |
622 |
$12K |
| 95117 |
|
902 |
469 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
705 |
568 |
$5K |
| 92551 |
|
517 |
475 |
$3K |
| 99173 |
|
564 |
517 |
$3K |
| 86580 |
|
391 |
364 |
$2K |
| 96127 |
|
498 |
461 |
$2K |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
192 |
144 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
921 |
667 |
$982.73 |
| 96160 |
|
520 |
478 |
$920.78 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
150 |
119 |
$818.70 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,939 |
1,440 |
$638.10 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
918 |
667 |
$618.13 |
| 36415 |
Collection of venous blood by venipuncture |
96 |
90 |
$271.35 |
| 3078F |
|
5,143 |
3,722 |
$101.18 |
| 81002 |
|
47 |
39 |
$62.51 |
| 3074F |
|
3,810 |
2,788 |
$25.81 |
| 3075F |
|
832 |
615 |
$20.00 |
| 3079F |
|
181 |
131 |
$10.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
261 |
187 |
$0.00 |
| 3008F |
|
422 |
382 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
4,144 |
2,836 |
$0.00 |
| 3077F |
|
35 |
25 |
$0.00 |